ArticleCureus2026
Too Massive and Too Atypical to Be Benign: The Unexpected Face of a Giant Adrenal Myelolipoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal myelolipomas (AMLs) are rare benign tumors composed of adipose and myeloid tissue. They are most often discovered incidentally and generally remain small in size. However, giant forms can radiologically mimic a malignant tumor, leading to aggressive investigations and treatment. We report the case of a patient who was hospitalized for investigation of a right adrenal mass, revealed by lumbar pain. An abdominal CT scan showed a large, heterodense interhepatorenal mass exerting a mass effect on the ipsilateral kidney with peripheral calcifications. The mass was excised and submitted for histological evaluation. The results of the histological study revealed an AML. Giant myelolipomas are rare and represent a real diagnostic challenge. Their large size, heterogeneous components, and necrotic or hemorrhagic changes can mimic a malignant tumor. Surgery remains indicated in cases of diagnostic uncertainty, compressive symptoms, or tumors larger than 6 cm. Histology remains the only way to establish a definitive diagnosis. This case highlights the difficulty of distinguishing a giant myelolipoma from a malignant adrenal tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.